Related content

Primary Central Nervous System Lymphoma: Treatment with Chemotherapy and Radiotherapy

By Sarazin M.   Ameri A.   Monjour A.   Nibio A.   Poisson M.   Delattre J.Y.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2003-2007

Elsevier

Access to resources Recommend Favorite

Angiogenesis in primary central nervous system lymphoma (PCNSL)

By Takeuchi Hiroaki   Matsuda Ken   Kitai Ryuhei   Sato Kazufumi   Kubota Toshihiko  

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic delay in primary central nervous system lymphoma

By Haldorsen Ingfrid S.   Espeland Ansgar   Larsen John Ludvig   Mella Olav  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 728-734

Informa Healthcare

Access to resources Recommend Favorite

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

By Silvani A.   Salmaggi A.   Eoli M.   Lamperti E.   Broggi G.   Marras C.   Fariselli L.   Milanesi I.   Fiumani A.   Gaviani P.   Erbetta A.   Giovagnoli A.   Pollo B.   Botturi A.   Boiardi A.  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite